Delivery Order SPE2DB25D3201-SPE2DB25FNWHD
- Not listed
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $12,446.16 firm fixed-price delivery order is for the supply of LAZCLUZE 240 MG TABLET 30S, a medical product, with a completion date of July 10, 2025. The contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,446.16 Firm Fixed Price delivery order contract is for the supply of 4568726454 ! LAZCLUZE 240 MG TABLET 30S. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor, and the place of performance is Conshohocken, Pennsylvania. This...
- The U.S. Defense Logistics Agency (DLA), through its Medical Supply Chain division, awarded a delivery order valued at $16,589.43 to AmerisourceBergen Drug Corp on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- The Defense Logistics Agency awarded a $4,027.02 delivery order to AmerisourceBergen Drug Corp for Quilpta 60 mg tablets (30-count package) on August 1, 2025, with an ultimate completion date of August 4, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $10,586.87 to AmerisourceBergen Drug Corp for pharmaceutical products and medical supplies. This firm fixed-price delivery order, issued on August 5, 2025, with an ultimate completion date of August 5, 2025, represents a non-competitive set-aside contract and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $46,912.02 to AmerisourceBergen Drug Corp on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents performance at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills...
- The Defense Logistics Agency awarded a delivery order valued at $1,219.17 to AmerisourceBergen Drug Corp on September 11, 2025, with an ultimate completion date of September 12, 2025. The order is for pharmaceutical products identified as "4569424878 ! DT 1C 2.25X4 700/RL 6RL/BX DHAPCL" under a firm fixed price contract type with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $12,185.65 to AmerisourceBergen Drug Corp on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The delivery order will be performed at...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $7,169.99 to AmerisourceBergen Drug Corp on August 18, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreement with DLA. The award is being fulfilled from the contractor's corporate office location in Conshohocken, Pennsylvania, and the specific...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $23,237.52 to AmerisourceBergen Drug Corp on August 21, 2025, with an ultimate completion date of August 22, 2025. This firm fixed-price delivery order, issued under a competitively awarded contract with no set-aside designation, will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- SPE2DB25D3201Indefinite Delivery Contract
- SPE2DB25D3201-SPE2DB25FNWHDDelivery Order
The Defense Logistics Agency awarded a $12,449.18 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Lazcluze 80 mg, with performance at the company's headquarters in Conshohocken, Pennsylvania, and completion targeted for September 30, 2025. This non-set-aside contract was competitively awarded on September 9, 2025, under firm fixed pricing terms and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. This delivery order is executed under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply medications, vaccines, and medical commodities across multiple therapeutic domains to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The award reflects AmerisourceBergen's established capability as a major pharmaceutical distributor to meet federal procurement requirements and supports DLA's medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.4k | 9/9/25 |